相关实验视频
Updated: Jun 7, 2025
04:33
Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
562
周围抗咳药影响猫的气管支气管咳的时间特征
Ivan Poliacek1, Marcel Veterník1, Lukas Martvon2
1Institute of Medical Biophysics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Journal of applied physiology (Bethesda, Md. : 1985)
|November 19, 2024
概括
周围抗咳药物,3-氨基基酸和levodropropizine,减少了猫的咳频率和强度. 这些药物通过延长阶段改变了咳运动模式,与中央抗咳药不同.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统生理学 呼吸系统生理学
- 神经科学是一个神经科学.
背景情况:
- 外围抗咳药物对咳的时空动态的影响在很大程度上仍未被探索.
- 假设外围抗咳药物通过延长其各个阶段来修改咳运动模式.
研究的目的:
- 为了研究周围作用的抗咳药物,3-aminopropylphosphinic acid (3APPi) 和levodropropizine (Levo) 对麻醉猫咳的时空特征的影响.
- 为了比较由外围抗咳剂引起的咳运动模式变化与由中央作用剂引起的变化.
主要方法:
- 麻醉后自发呼吸的猫被静脉注射3APPi (5毫克/公斤) 或Levo (3毫克/公斤).
- 通过机械气管刺激诱导咳,并分析了时空咳参数.
- 监测心肺呼吸系统数据,包括腹膜和腹肌活动.
主要成果:
- 3APPi和Levo都显著减少了咳的数量和呼吸咳的努力.
- 莱沃的管理也导致了激发性咳努力的显著减少.
- 两种药物都延长了吸气阶段,吸气-呼气过渡,咳隔膜总活性和咳周期总持续时间. 莱沃进一步延长了呼气阶段.
- 3APPi缩短了隔膜和腹部活动之间的重叠. 利沃降低了呼吸速率,3APPi延长了呼气阶段.
结论:
- 边缘作用的抗咳药物通过改变咳运动模式的时间特征的机制来抑制咳.
- 观察到的咳时空特征的变化与中央作用的抗咳药物引起的变化不同,这表明不同的神经通路受到影响.
- 咳中心模式发生器的运动输出通过外围和中央的抗咳干预不同地调节.
相关概念视频
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
232
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
232
01:16Drugs Used in Upper Respiratory Disorders: Overview
177
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
177
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
244
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
244
01:26Cholinergic Antagonists: Therapeutic Uses
716
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
716
01:22Trachea
1.6K
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
1.6K
01:24Antiasthma Drugs: Methylxanthines
196
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
196